Visual Snow Initiative (VSI):
About VSI’s Research Funding, Mission, and Impact
Every donation to the Visual Snow Initiative (VSI) directly funds scientific research to better understand Visual Snow Syndrome (VSS), develop safe and effective treatments, and ultimately work toward a cure. Your support powers critical studies led by a global network of experts across multiple countries and scientific disciplines.
Founded in 2018 by Sierra Domb, who personally faced the challenges of VSS and the medical field’s historical neglect of the condition, VSI brings together leading researchers and medical professionals worldwide. United by a common goal, they work to expand scientific knowledge, improve patient care, and accelerate meaningful progress in managing this complex neurological condition.
Donations to VSI directly support international research efforts, funding clinical trials and scientific studies. As research progresses, VSI’s team simultaneously builds global collaborations, raises awareness among public and medical communities, and creates multimodal educational resources designed to help both patients and medical professionals.
Contributing to Scientific Progress in Visual Snow Syndrome
Visual Snow Syndrome affects millions across all age groups worldwide, yet it has been historically under-recognized and under-researched. VSI was founded to change that. By convening leaders in neurology, ophthalmology, neuroscience, pharmacology, neuroimaging, psychology, clinical medicine, and related fields, VSI enables the kind of interdisciplinary collaboration essential to advancing understanding and treatment of VSS.
Your contribution plays a direct role in supporting this mission. Every donation to VSI helps fund scientific research, clinical trials, and global projects that drive meaningful change for those affected by Visual Snow Syndrome.
Our Global Research Impact
VSI supports a wide range of scientific investigations, including:
➤ Advancing understanding of VSS pathophysiology:
Studying the neurological processes and brain activity involved in the condition.
➤ Identifying biomarkers and neural mechanisms:
Uncovering measurable indicators to aid in diagnosis, monitoring, and treatment development.
➤ Developing pharmacological and non-invasive treatments:
Collaborating with pharmacology experts to ensure therapeutic studies are safe, evidence-based, and tailored to the complexities of VSS.
➤ Creating diagnostic tools and multimodal resources:
Designing accessible materials to assist with diagnosis, improve physician-patient communication regarding VSS, and improve quality of life for individuals affected by the condition.
